Viagra Research Today is a free monthly online journal that collates and summarizes the latest research about Viagra, including details on sildenafil, erectile dysfunction, impotence, side-effects, alternatives. | ||||||||
|
The effect of sildenafil citrate and pentoxifylline combined treatment in the management of erectile dysfunction.Ozdal OL, Ozden C, Gokkaya S, Urgancioglu G, Aktas BK, Memis A Department of Urology, Numune Education and Research Hospital, Cevizlidere Mah. 14. Cad. Balgat 12/25, Ankara, 06100, Turkey, cuneytozden@hotmail.com. INTRODUCTION: In the present study, we evaluated the efficacy of sildenafil and pentoxifylline combined therapy in the treatment of vasculogenic erectile dysfunction. METHODS: Sixty-eight patients with various degrees and types of vasculogenic erectile dysfunction were included in the study. The patients were recommended to take oral sildenafil (minimum two 50-mg tablets/week) 1 h prior to sexual intercourse for 4 weeks. After 4 weeks of washout period, patients were recommended to take combined therapy (minimum two 50-mg tablets/week sildenafil 1 h prior to sexual intercourse and 1.2 g of pentoxifylline/day divided into three doses) for an additional 4-week period. Both treatment regimes were evaluated with the international index of erectile function (IIEF). RESULTS: Mean IIEF score was higher after sildenafil treatment when compared to pre-treatment score (14.2 +/- 4.3 and 8.6 +/- 4.2, respectively, P < 0.05). Likewise after the combination treatment, mean IIEF score was higher when compared to pre-treatment score (18.1 +/- 5.2 and 8.6 +/- 3.8, respectively, P < 0.05). The increase in the IIEF score was 5.62 +/- 2.08 in the sildenafil only group whereas increase in the IIEF score was 9.51 +/- 3.77 in the combination therapy group. There was a statistically significant increase in the combination group when compared to the sildenafil only group (P < 0.001). CONCLUSION: Our study suggests that use of sildenafil citrate and pentoxifylline combined therapy could be effective in the management of patients with vasculogenic erectile dysfunction. Published 3 September 2007 in Int Urol Nephrol.
© 2004-2008 Viagra Research Today. All Rights Reserved. |
| ||||||